Clarke and coworkers also performed an exploratory analysis in a small case series, observing a significant association between intraepithelial TIL and BRCA1 mutations or promoter methylation causing loss of expression, mainly in high-grade serous ovarian cancer [60]. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.